Mechanical Prosthetic Heart Valve Thrombosis in a Patient Receiving Rivaroxaban
Author(s) -
D Carvalho,
Ana Braga,
Ilídio de Jesus,
José Neves
Publication year - 2019
Publication title -
cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.547
H-Index - 63
eISSN - 1421-9751
pISSN - 0008-6312
DOI - 10.1159/000501361
Subject(s) - rivaroxaban , medicine , discontinuation , warfarin , mechanical heart valve , mechanical heart , thrombosis , mechanical valve , prosthesis , surgery , cardiology , atrial fibrillation , heart valve
Direct oral anticoagulants are not approved for use in patients with mechanical valves. When used to replace vitamin K antagonists, they may cause catastrophic consequences. The authors describe the case of a patient who, after discontinuation of warfarin and introduction of rivaroxaban, developed thrombosis of his mechanical mitral prosthesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom